Referenzen
↑1 | Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain. 2021 Jul 1;162(Suppl 1):S5-S25. doi: 10.1097/j.pain.0000000000002268. PMID: 33729211. |
---|---|
↑2 | Maharajan MK, Yong YJ, Yip HY, Woon SS, Yeap KM, Yap KY, Yip SC, Yap KX. Medical cannabis for chronic pain: can it make a difference in pain management? J Anesth. 2020 Feb;34(1):95-103. doi: 10.1007/s00540-019-02680-y. Epub 2019 Sep 18. PMID: 31535218. |
↑3 | Karst M, Wippermann S, Ahrens J. Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs. 2010 Dec 24;70(18):2409-38. doi: 10.2165/11585260-000000000-00000. PMID: 21142261. |
↑4, ↑9 | Aviram J, Pud D, Gershoni T, Schiff-Keren B, Ogintz M, Vulfsons S, Yashar T, Adahan HM, Brill S, Amital H, Goor-Aryeh I, Robinson D, Green L, Segal R, Fogelman Y, Tsvieli O, Yellin B, Vysotski Y, Morag O, Tashlykov V, Sheinfeld R, Goor R, Meiri D, Eisenberg E. Medical cannabis treatment for chronic pain: Outcomes and prediction of response. Eur J Pain. 2021 Feb;25(2):359-374. doi: 10.1002/ejp.1675. Epub 2020 Nov 9. PMID: 33065768. |
↑5, ↑8 | Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017 May;31(5):569-575. doi: 10.1177/0269881117699616. Epub 2017 Apr 4. PMID: 28372506. |
↑6 | Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016 Jun;17(6):739-44. doi: 10.1016/j.jpain.2016.03.002. Epub 2016 Mar 19. PMID: 27001005. |
↑7 | Kvamme SL, Pedersen MM, Rømer Thomsen K, Thylstrup B. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduct J. 2021 Jul 10;18(1):72. doi: 10.1186/s12954-021-00520-5. PMID: 34246279; PMCID: PMC8272272. |
↑10 | Schmidt-Wolf G, Cremer-Schaeffer P. Begleiterhebung zur Anwendung von Cannabisarzneimitteln in Deutschland – Zwischenauswertung [Interim analysis of the survey accompanying insurance-covered prescriptions of cannabis-based medicines in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):845-854. German. doi: 10.1007/s00103-019-02968-0. PMID: 31143965. |